Interleukin 27 inhibits cytotoxic T-lymphocyte-mediated platelet destruction in primary immune thrombocytopenia

Blood

Volumn 124, Issue 22, 2014, Pages 3316-3319

  Zhou, Hai ^a   Qiu, Ji Hua ^a   Wang, Tong ^b   Yu, Ying Yi ^a   Liu, Xue Na ^a   Li, Xin ^a   Wang, Ya Wen ^a   Hou, Yu ^a   Li, Li Zhen ^a   Liu, Xin Guang ^b   Hou, Ming ^a,b   Peng, Jun ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EOMESODERMIN; GRANZYME A; GRANZYME B; INTERLEUKIN 27; PERFORIN; ENZYME INHIBITOR; GRANZYME;

APOPTOSIS; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; CELL DESTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOMODULATION; PLATELET DESTRUCTION; PROTEIN EXPRESSION; ANTAGONISTS AND INHIBITORS; BLOOD; CELL CULTURE; DRUG EFFECTS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; THROMBOCYTE;

APOPTOSIS; BLOOD PLATELETS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; ENZYME INHIBITORS; GRANZYMES; HUMANS; INTERLEUKIN-27; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84911872418     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-06-580084     Document Type: Article

References (25)

1. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11): 2386-2393.
2. Olsson B, Andersson PO, Jern°as M, et al. T-cellmediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9(9):1123-1124.
3. Chow L, Aslam R, Speck ER, et al. A murine model of severe immune thrombocytopenia is induced by antibody-and CD81 T cell-mediated responses that are differentially sensitive to therapy. Blood. 2010;115(6):1247-1253.
4. Audia S, Samson M, Mahévas M, et al. Preferential splenic CD8(1) T-cell activation in rituximab-nonresponder patients with immune thrombocytopenia. Blood. 2013;122(14):2477-2486.
5. Guo L, Yang L, Speck ER, et al. Allogeneic platelet transfusions prevent murine T-cellmediated immune thrombocytopenia. Blood. 2014;123(3):422-427.
6. Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood. 1996;87(10): 4245-4254.
7. Panitsas FP, Theodoropoulou M, Kouraklis A, et al. Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood. 2004;103(7): 2645-2647.
8. Hunter CA, Kastelein R. Interleukin-27: balancing protective and pathological immunity. Immunity. 2012;37(6):960-969.
9. Awasthi A, Carrier Y, Peron JP, et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol. 2007;8(12):1380-1389.
10. Pickens SR, Chamberlain ND, Volin MV, et al. Local expression of interleukin-27 ameliorates collagen-induced arthritis. Arthritis Rheum. 2011; 63(8):2289-2298.
11. Li TT, Zhang T, Chen GM, et al. Low level of serum interleukin 27 in patients with systemic lupus erythematosus. J Investig Med. 2010;58(5): 737-739.
12. Liu XG, Ren J, Yu Y, et al. Decreased expression of interleukin-27 in immune thrombocytopenia. Br J Haematol. 2011;153(2):259-267.
13. Zhao C, Li X, Zhang F, Wang L, Peng J, Hou M. Increased cytotoxic T-lymphocyte-mediated cytotoxicity predominant in patients with idiopathic thrombocytopenic purpura without platelet autoantibodies. Haematologica. 2008;93(9): 1428-1430.
14. Morishima N, Owaki T, Asakawa M, Kamiya S, Mizuguchi J, Yoshimoto T. Augmentation of effector CD81 T cell generation with enhanced granzyme B expression by IL-27. J Immunol. 2005;175(3):1686-1693.
15. Nugent D, McMillan R, Nichol JL, Slichter SJ. Pathogenesis of chronic immune thrombocytopenia: increased platelet destruction and/or decreased platelet production. Br J Haematol. 2009;146(6):585-596.
16. Zhang F, Chu X, Wang L, et al. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura. Eur J Haematol. 2006; 76(5):427-431.
17. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113(26):6511-6521.
18. Diveu C, McGeachy MJ, Boniface K, et al. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol. 2009; 182(9):5748-5756.
19. Shinozaki Y, Wang S, Miyazaki Y, et al. Tumorspecific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. Int J Cancer. 2009;124(6):1372-1378.
20. Olsson B, Jern°as M, Wadenvik H. Increased plasma levels of granzymes in adult patients with chronic immune thrombocytopenia. Thromb Haemost. 2012;107(6):1182-1184.
21. Thomas HE, Trapani JA, Kay TW. The role of perforin and granzymes in diabetes. Cell Death Differ. 2010;17(4):577-585.
22. Intlekofer AM, Takemoto N, Wherry EJ, et al. Effector and memory CD81 T cell fate coupled by T-bet and eomesodermin. Nat Immunol. 2005; 6(12):1236-1244.
23. Joshi NS, Cui W, Chandele A, et al. Inflammation directs memory precursor and short-lived effector CD8(1) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007; 27(2):281-295.
24. Juedes AE, Rodrigo E, Togher L, Glimcher LH, von Herrath MG. T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J Exp Med. 2004;199(8):1153-1162.
25. Sutherland AP, Joller N, Michaud M, Liu SM, Kuchroo VK, Grusby MJ. IL-21 promotes CD81 CTL activity via the transcription factor T-bet. J Immunol. 2013;190(8):3977-3984.